What changed 10-Q

Item 1A. Risk Factors

2026-02-06 compared with 2025-11-10 · 10 added, 6 removed, 88 unchanged (15% of the section changed)

80 unchanged sentences

within those warrants.

As of September 30, 2025, there were warrants

outstanding to purchase an aggregate of 8,307,038 shares of our Common Stock at exercise prices ranging from $0.0001 to $582.00 per share,

84,872 shares issuable upon exercise of outstanding options at exercise prices ranging from $19.00 to $4,209.00 per share and restricted

stock units totaling 5,457.

As of December 31, 2025, there were warrants outstanding

to purchase an aggregate of 8,282,037 shares of our Common Stock at exercise prices ranging from $0.0001 to $582.00 per share, 80,593

shares issuable upon exercise of outstanding options at exercise prices ranging from $19.00 to $4,209.00 per share and restricted stock

units totaling 2,202.

We may also grant additional options, warrants or equity awards.

To the extent such shares are issued, the

interest of holders of our Common Stock will be diluted.

To the extent such shares are issued, the interest

of holders of our Common Stock will be diluted.

Moreover, we are obligated to issue shares of

4 unchanged sentences

shares of our Common Stock, further diluting the interest of holders of our Common Stock.

Unregistered sales of equity securities

no unregistered sales of equity securities during the three months period ended December 31, 2025.

Defaults Upon Senior Securities

Mine Safety Disclosures

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.